Drug discounts should be benefitting beneficiaries—not drug industry middlemen.
Trump Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients
CUA commends the Trump Admin proposal to fix the drug purchasing system to make sure rebates are given to patients, not drug industry middlemen. This will be critical in protecting access to care for millions of patients living with chronic conditions. http://bit.ly/2Sk1fxe
“The proposed changes will ensure California patients – many of whom suffer from debilitating chronic conditions – receive the benefit from drug rebates provided by manufacturers. Pharmacy benefit managers have traditionally benefited from these discounts, and it’s time the rebates make it directly into the hands of consumers. The Administration’s new proposal is a great step toward making sure patients with chronic conditions receive the care and treatments they need.”
California Chronic Care Coalition
Click link to view article